NIFTY23,3670.21%
SENSEX74,2430.16%
BANKNIFTY54,4960.35%
NIFTY IT29,0100.99%
PHARMA24,2480.29%
AUTO26,1660.08%
FMCG48,3020.18%
METAL13,2221.60%
REALTY768.900.56%
ENERGY40,3460.25%
NIFTY23,3670.21%
SENSEX74,2430.16%
BANKNIFTY54,4960.35%
NIFTY IT29,0100.99%
PHARMA24,2480.29%
AUTO26,1660.08%
FMCG48,3020.18%
METAL13,2221.60%
REALTY768.900.56%
ENERGY40,3460.25%

JP Morgan Maintains Bullish Stance on Titan Following Analyst Day Meet

Global brokerage firm JP Morgan has reaffirmed its 'overweight' rating on Tata Group's jewellery stock, Titan, following the company's analyst day meet. The stock opened at ₹4,269 per share on Thursday, June 5, as compared to the previous close of ₹4,231.

JP Morgan's analysts highlighted Titan's ability to maintain growth despite elevated gold prices, citing the company's strategic advantages, such as keeping jewellery affordable through measures like offering 18-carat and 14-carat products, expanding its lightweight jewellery range, and running demand-generation initiatives. The brokerage also pointed out that Titan's watches segment and TEAL business continue to deliver robust growth.

Discretionary PeersTitanChange
DMART13.5%-
TRENT12.2%-
NYKAA11.8%-
Titan21%+7.2%

Read also: HNGIL Warns Bira91 Investors of Potential Insolvency Proceedings Over Outstanding Dues

The brokerage firm increased its FY27 and FY28 EPS estimates by 4% and 6%, respectively, reflecting stronger revenue expectations. JP Morgan forecasts a revenue CAGR of 13% and an EPS CAGR of 20% over FY26–FY28, which it believes will underpin continued outperformance in the stock. On valuations, the stock is trading lower compared to other discretionary peers, providing relative comfort.

Titan Company posted a 35.4% year-on-year increase in consolidated net profit attributable to the owners of the group, reaching ₹1,179 crore for the quarter ended March 31, 2026. The company also reported a sharp 80.5% rise in consolidated revenue from operations to ₹26,920 crore in Q4FY26, compared with ₹14,916 crore in the same quarter a year earlier.

Titan Q4 Results 2026Previous YearCurrent YearChange
Consolidated Net Profit₹870 crore₹1,179 crore35.4%
Consolidated Revenue from Operations₹14,916 crore₹26,920 crore80.5%
Standalone Net Profit₹870 crore₹1,124 crore29.2%
Standalone Revenue from Operations₹13,477 crore₹23,934 crore77.6%

The company's Earnings Before Interest and Taxes (EBIT) rose 28% to ₹1,875 crore, up from ₹1,470 crore reported in Q4FY25. Additionally, Titan's board has recommended a dividend of ₹15 per equity share, subject to shareholder approval.

Read also: ICICI Prudential and HDFC Mutual Fund Restrict Gold ETF Investments: Impact on Investors and SIPs Unchanged

The share price trend of Titan has remained largely positive despite weak market sentiments. The jewellery stock has gained 4% in a week, but has fallen 3% in a month. On a year-to-date (YTD) basis, the stock has gained over 4.67%, and in a year, it has gained 21%. Looking at the broader level, Titan shares have delivered 48% returns in three years and multibagger returns of 152% in five years.

Investor Takeaway

Investors should consider Tata Group stock as JP Morgan maintains an 'overweight' rating with a target price of ₹5,400 per share.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.